Overview
No overview information available.
Indication
适用于与其它抗逆转录病毒药物联合用药，治疗HIV感染。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2020/03/31 | Phase 3 | Terminated | |||
2010/07/21 | Phase 4 | Completed | Sociedad Andaluza de Enfermedades Infecciosas |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Lopinavir and Ritonavir Tablets | 国药准字H20234040 | 化学药品 | 片剂 | 2/26/2024 | |
| Lopinavir and Ritonavir Tablets | 国药准字HJ20181115 | 化学药品 | 片剂 | 11/16/2022 | |
| Lopinavir and Ritonavir Tablets | 国药准字H20233907 | 化学药品 | 片剂 | 6/30/2023 | |
| Lopinavir and Ritonavir Tablets | 国药准字H20247241 | 化学药品 | 片剂 | 10/14/2024 | |
| Lopinavir and Ritonavir Tablets | 国药准字HJ20170213 | 化学药品 | 片剂 | 12/20/2021 | |
| Lopinavir/Ritonavir Oral Solution | 国药准字HJ20130773 | 化学药品 | 口服溶液剂 | 6/7/2023 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.